Catalyst Wire Dossier Catalyst Wire Dossier

EGF Cancer Vaccine

· Bioven Europe
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EGF Cancer Vaccine, covering 2019-09-10 to 2019-09-10. Get the full timeline:

Most recent: Clinical Trial Update: Safety & Efficacy Study of EGF Cancer Vaccine to Treat Stage IV Biomarker Positive, Wild Type EGF-R NSCLC Patients [Phase 3]

See pricing